Lutetium-177

Uppsala and Garching/Munich, August 20, 2026 Akiram Therapeutics has entered into a Lutetium-177 (Lu-177) supply agreement with ITM Isotope...

MORGES, Switzerland, July 20, 2026 Spectrum Dynamics Medical has announced the launch of the All-Energy Enhancement for its FDA-cleared,...

MELBOURNE, Australia, and INDIANAPOLIS, Ind., July 21, 2026 Telix Pharmaceuticals announced that the first patient has been dosed in...

BOTHELL, Wash., July 20, 2026 Immunome, Inc. (Nasdaq: IMNM) announced that the first patient has been dosed in the...

Melbourne, Australia, and Indianapolis, Indiana, United States, July 2, 2026 Telix announced a significant regulatory milestone after a successful...

MELBOURNE, Australia & INDIANAPOLIS, U.S., June 2, 2026 Telix Pharmaceuticals announced positive Part 1 data from its global Phase...